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Causes of Post-colonoscopy Colorectal Cancers Based on World 
Endoscopy Organization System of Analysis
BACKGROUND & AIMS: Postcolonoscopy colorectal cancer
(PCCRC) is CRC diagnosed after a colonoscopy in which no
cancer was found. A consensus article from the World
Endoscopy Organization (WEO) proposed an approach for
investigating and categorizing PCCRCs detected within 4
years of a colonoscopy. We aimed to identify cases of PCCRC
and the factors that cause them, test the WEO system of
categorization, quantify the proportion of avoidable
PCCRCs, and propose a target rate for PCCRCs detected
within 3 years of a colonoscopy that did not detect CRC.
METHODS: We performed a retrospective analysis of 107
PCCRCs identified at a single medical center in England from
January 1, 2010, through December 31, 2017 using coding
and endoscopy data. For each case, we reviewed clinical,
pathology, radiology, and endoscopy findings. Using the
WEO recommendations, we performed a root-cause analysis
of each case, categorizing lesions as follows: possible missed
lesion, prior examination adequate; possible missed lesion,
prior examination inadequate; detected lesion, not resected;
or likely incomplete resection of previously identified
lesion. We determined whether PCCRCs could be attributed
to the colonoscopist for technical or decision-making rea-
sons, and whether the PCCRC was avoidable or unavoidable,
based on the WEO categorization and size of tumor. The
endoscopy reporting system provided performance data
for individual endoscopists. RESULTS: Of the PCCRCs
identified, 43% were in high-risk patients (those with
inflammatory bowel disease, previous CRC, previous multi-
ple large polyps, or hereditary cancer syndromes) and 66%
were located distal to the hepatic flexure. There was no
correlation between postcolonoscopy colorectal tumor size
and time to diagnosis after index colonoscopy. Bowel
preparation was poor in 19% of index colonoscopies, and
only 36% of complete colonoscopies had adequate photo-
documentation of completion. Development of 73% of
PCCRCs was determined to be affected by technical endo-
scopic factors, 17% of PCCRCs by administrative factors
(follow-up procedures delayed/not booked by administra-
tive staff), and 27% of PCCRCs by decision-making factors.
Twenty-seven percent of PCCRCs were categorized as
possible missed lesion, prior examination adequate; 58% as
possible missed lesion, prior examination inadequate; 8% as
detected lesion, not resected; and 7% as incomplete resec-
tion of previously observed lesion; 89% were deemed to be
avoidable. CONCLUSIONS: In a retrospective analysis of
PCCRCs, using the WEO system of categorization, we found
43% to occur in high-risk patients; this might be reduced
with more vigilant surveillance. Measures are needed to
reduce technical, decision-making, and administrative fac-
tors. We found that 89% of PCCRCs may be avoidable. If half
of avoidable PCCRCs could be prevented, the target rate of
2% for the PCCRC-3y (cancer diagnosed between 6 and 36
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Colonoscopy is the reference standard investigationfor prevention and diagnosis of colorectal cancer
(CRC). However, sometimes CRC is diagnosed after a colo-
noscopy that has not found cancer. These CRCs are called
postcolonoscopy colorectal cancers (PCCRCs),1 a term
recently endorsed by the World Endoscopy Organisation
(WEO).2
There is now an extensive literature exploring factors
contributing to PCCRCs and interval cancers that is both
exemplified and well summarized by Tollivoro et al.3 Most
of these studies have used linked datasets, or case-control
design to identify factors associated with PCCRCs, such as
right-sided cancers, older patients, polymorbid patients, fe-
male sex, diverticular disease, previous surgery, previous/
family history of CRC, cancer biology, and endoscopist fac-
tors (eg, adenoma detection rate [ADR] and colonoscopy
volume). These studies benefit from large numbers, making
it possible to demonstrate statistically significant associa-
tions. However, they do not provide the detail required to
understand exactly what led to the PCCRC. As such, advice
to services of how to reduce PCCRCs is general, remote from
the real world, and will therefore have relatively little
impact.4–6
In contrast, there is a smaller literature that reviews
individual cases. These studies often have small
numbers,7–9 or there is case selection limiting their
generalizability.10 For example, the largest study of this
type drew patients from 8 large randomized controlled
trials.10 All these trials had significant exclusion criteria,
most excluding patients with the highest risk of PCCRC:
previous cancer, the very young or very old, inflamma-
tory bowel disease (IBD), comorbid patients, and patients
with high-risk family history. In contrast, the study of
Samadder et al.7 was population based (covering 85% of
the population of Utah) and included a review of 36
charts.
The Joint Advisory Group on Gastrointestinal Endoscopy
requires endoscopy services to identify PCCRCs, perform
root-cause analysis, and introduce improvements to reduce
PCCRC rates.11,12 The WEO consensus recommends services
review their PCCRCs “to determine the most plausible
explanation for the PCCRC,” and it made recommendations
for investigators to follow.2 The intention was to provide a
guide and bring consistency so that future reports could be
compared and contrasted. The WEO recommended 2
different PCCRC intervals. A 6- to 48-month interval for
quality improvement based on case review on the basis that
the “most plausible explanation” for cancers appearing after
48 months is “likely new cancer.” A shorter, 6- to 36-month
interval (PCCRC-3y) was proposed for quality assurance or
benchmarking.2 The WEO group recognized that their rec-
ommendations needed to be tested.
With this, and the limitations of previous studies in
mind, the aim of this study was to apply the WEO recom-
mendations in a well-defined and stable population to
 Perform a route-cause analysis for each PCCRC case
appearing in the 6- to 48-month interval
 Define factors that lead to PCCRCs
 Categorize PCCRCs using the WEO method
 Determine the strengths and limitations of the WEO
methodology
 Determine what proportion of PCCRCs are preventable
and propose a target for PCCRC-3y rates
 Make recommendations of how to reduce PCCRC rates
Methods
Clinical Setting
The study identified and reviewed PCCRCs at Gloucester-
shire Hospitals over an 8-year period. Gloucestershire Hospitals
WHAT YOU NEED TO KNOW
BACKGROUND AND CONTEXT
Post-colonoscopy colorectal cancer (PCCRC) is CRC
diagnosed after a colonoscopy in which no cancer was
found. We used the World Endoscopy Organization
(WEO) methodology for determining the etiology of
PCCRCs and categorizing them.
NEW FINDINGS
In an analysis of PCCRCs detected over an 8-year period,
we found 89% to be avoidable, based on WEO criteria,
and 43% to occur in high-risk patients. Causes included
possible missed lesion, adequate colonoscopy (27%);
possible missed lesion, inadequate colonoscopy (58%);
detected, unresected lesion (8%); and incomplete
resection of detected lesion (7%).
LIMITATIONS
Earlier cases had less complete documentation and some
measures, such a bowel preparation quality, were
subjective. The center is a tertiary referral center for
complex polypectomy, which may influence
categorization.
IMPACT
We identified factors that can be addressed to reduce
rates of PCCRC at a local level. We propose aiming for
a rate of fewer than 2% of PCCRCs within 3 years of a
colonoscopy.
Abbreviations used in this paper: ADR, adenoma detection rate; BCSP,
bowel cancer screening programme; CIR, cecal intubation rate; CRC,
colorectal cancer; IBD, inflammatory bowel disease; ICD-10, International
Classification of Diseases, 10th Revision; MDT, multidisciplinary team;
PCCRC, postcolonoscopy colorectal cancer; PCCRC-3y, cancer diag-
nosed between 6 and 36 months after index colonoscopy; PDR, polyp
detection rate; PICI, performance indicator of cecal intubation; WEO,
World Endoscopy Organisation.
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is the principal provider of health care services to the county of
Gloucestershire, England (population 628,000), which has a
slight preponderance of people aged >65.13 The endoscopy
service is delivered from 4 sites. The service has a single
governance structure, integrated electronic reporting system,14
and 1 group of colonoscopists provides all the colonoscopies
(6000–7000 procedures/year). The service participates in the
National Bowel Cancer Screening Programme (BCSP) and has
delivered colonoscopy training courses since 1999.15
Case Selection
Using International Classification of Diseases, 10th Revision
(ICD-10) codes for malignant neoplasm of the colon (ICD-10
C18.0-C18.9), rectosigmoid (ICD-10 C19), rectum (ICD-10 C20),
and anus (ICD-10 C21), all CRCs (January 1, 2010 to December
31, 2017) in which a colonoscopy had been performed in the
preceding 6 to 48 months were identified from the hospital
clinical database. A 6- to 48-month interval was chosen in
accordance with the WEO guideline for case review. All adult
patients older than 18 were included. Cases within 6 months of
a cancer diagnosis, appendiceal cancers (ICD-10, C18.1),
neuroendocrine tumors, and squamous cell cancers of the anus
(ICD-10, C21) were excluded.
Benchmarking data for the most contemporary (all colo-
noscopy for years 2011–2013) PCCRC-3y rates was obtained
from the UK Colorectal Cancer Intelligence Hub’s colorectal
cancer data repository (CORECT-R). This hub links cancer
registry and routinely collected hospital data (including colo-
noscopies) to identify PCCRCs and calculate rates.16 Data were
available for all colonoscopy providers in England and PCCRC-
3y rates were ranked in deciles.
Data Collection
For each case, the clinical record, pathology, radiology,
endoscopy electronic systems, and printed Polaroid photo-
graphs were reviewed to collect data required by the WEO
method2 (Figure 1). There is a minimum dataset for pathology
reporting of cancer in England, including exact size of the tu-
mor. For patients who had multiple colonoscopies, that closest
to cancer diagnosis was regarded as the “index” colonoscopy.
However, data from earlier colonoscopies were also collected.
Root-Cause Analysis
A root-cause analysis (using the WEO categorization) was
undertaken for each PCCRC. The categorization involves a 3-
step process, which looks at the index colonoscopy in relation
to the location of the cancer. It has 4 categories (labeled A to D).
Step 1: Was an adenoma seen in the subsequent cancerous
bowel segment at index colonoscopy?
If No, proceed to Step 2; if Yes, proceed to Step 3.
Step 2: Was the cecum intubated and bowel preparation
good at index colonoscopy?
If Yes, PCCRC is categorized as “A”: possible missed lesion,
examination adequate.
If No, PCCRC is categorized as “B”: possible missed lesion,
examination inadequate.
Step 3: Was the lesion resected?
If No, PCCRC is categorized as “C”: detected lesion, not
resected.
If Yes, PCCRC is categorized as “D”: likely incomplete
resection.
An adequate colonoscopy was defined as a complete pro-
cedure with adequate bowel preparation. Completion was
deemed adequate if there was a photograph of the ileocecal
valve, appendiceal orifice, or terminal ileum. During the study
period, image capture was limited to Polaroid photographs and
relatively few pictures were taken, therefore 1 clear photo-
graph was considered sufficient. The reporting system had a
compulsory field for preparation with 3 options: “Good,”
“Satisfactory,” or “Poor.” “Good” and “Satisfactory” were
deemed adequate.
A “lesion” was defined, as per the WEO, as an advanced
adenoma >1 cm and/or with villous component and/or with
high-grade dysplasia.
Clinical records were reviewed to identify key management
decisions, patient preferences, and deviations from manage-
ment plans, for example, if a repeat procedure was recom-
mended but not booked within the specified time period (or not
at all), or the patient defaulted on an appointment.
Survival
To account for lead-time bias, survival should be calculated
from the date of index colonoscopy and not PCCRC diagnosis;
however, there is an additional potential bias: immortal time
bias.5 Patients with PCCRC must survive in the interval between
index colonoscopy and the diagnosis of PCCRC to be available
for survival analysis. For example, if a patient has a false
negative colonoscopy at time 0, and then dies for an unrelated
reason at 1 year (before being diagnosed with PCCRC) he or she
will not be included in PCCRC mortality data calculated from
the index colonoscopy. This would lead to falsely improved
survival times in PCCRC cases. To avoid this “immortal time”
bias, and to provide direct comparison with the results of the
Belgium PCCRC study,5 survival was calculated in patients still
alive at 3 years and 4 years after index colonoscopy
Avoidability
The default position of the WEO categorization is that
PCCRCs are avoidable, but this is not always the case. The au-
thors made a judgment as to whether a PCCRC was avoidable or
unavoidable. Small PCCRCs were categorized as unavoidable on
the basis that if growing by <5 mm/year they would not have
been present at the index colonoscopy. For example, a PCCRC
<20 mm found at 48 months was deemed unavoidable. Sub-
mucosal lesions resulting from local recurrence of cancer were
also deemed unavoidable.
In the NHS, all cancers must be discussed at multidisci-
plinary team (MDT) meetings before treatment, including all
cases with potential malignant pathology. In certain cases,
the patient may be deemed too unwell to proceed with
further investigations/treatment of/for their precancerous
pathology. Cases were deemed unavoidable if the patient
declined recommended follow-up, or the MDT felt their
comorbidities precluded them from further investigation. All
other PCCRCs were deemed avoidable based on contributory









and modifiable technical, decision-making, and/or adminis-
trative factors.
Attribution
The authors concluded the PCCRC could be attributed to an
individual colonoscopist for both technical and decision-making
reasons on the basis that a colonoscopy is more than just a
technical procedure. Thus, a PCCRC was deemed attributable in
1 or more of the following situations:
1. A PCCRC developed after a negative colonoscopy
(excluding very small PCCRCs), irrespective of ade-
quacy, on the basis a cancer or precursor lesion was
missed.
2. The colonoscopist did not arrange further investigations
after an inadequate colonoscopy or one in which po-
tential precursor lesions were observed but not treated.
3. The colonoscopist did not state a timeframe, or recom-
mended too long a timeframe, for repeat procedures.
The PCCRC was not deemed attributable in 1 or more of the
following situations:
1. Small PCCRCs (growing at <5 mm/year).
2. PCCRCs in which the colonoscopist had requested
prompt and appropriate further investigations that were
not booked within the stated timeframe (or at all) by the
administrative team.
Figure 1. Data collected
for each PCCRC. CT,
computed tomography.









3. When the decision about further procedure(s) lay with
another clinician.
For the purpose of exploring the relationship between
performance measures (such as cecal intubation rate [CIR])
and PCCRCs, a “technically attributable” rate for each indi-
vidual was calculated that excluded decision-making factors.
For each colonoscopist who had performed >200 proced-
ures, the rate of PCCRCs per 1000 colonoscopies was
calculated by dividing the number of PCCRCs that could be
attributed to them for technical reasons, divided by the
number of colonoscopies they had performed at Glouces-
tershire Hospitals during the study period. A PCCRC was felt
to be technically attributable to a colonoscopist if it was
incomplete (or lacked sufficient evidence of completion), or
otherwise adequate but where a lesion was likely missed or
incompletely excised.
Endoscopist Performance Data
The endoscopy reporting system provided performance
data for individual endoscopists including polyp detection rate
(PDR), CIR, sedation usage, and nurse-assessed comfort scores.
The data enable calculation of the Performance Indicator of
Cecal Intubation (PICI), a composite measure of intubation,
patient comfort, and use of midazolam sedation.17 ADR is not
routinely collected.
Statistics/Correlations
A scatterplot was produced to show the correlation be-
tween tumor size and delay to diagnosis. Scatterplots were
produced to illustrate the relationship of technically “attribut-
able” rates of PCCRC/1000 colonoscopies to numbers of pro-
cedures, PDR, CIR, and PICI. Only colonoscopists who had
performed >200 procedures were included. Pearson’s corre-
lation was performed where visual inspection suggested
asymmetry.
Analyses were performed using Microsoft Excel spread-
sheet (XP professional edition; Microsoft Corp, Redmond, WA)
and STATA v15 (StataCorp LP, College Station, TX).
Ethics
The project was registered as an audit with the hospital’s
Quality Improvement Department, and endorsed by the local
Caldicott Guardian, an individual responsible for protecting the
confidentiality of people’s health and care information, and
making sure it is used properly.18
Results
A total of 61,110 colonoscopies were performed in
Gloucestershire Hospitals between January 2006 and July
2017 with an unadjusted PCCRC-3y rate of 4.7% (95%
confidence interval 3.15%–6.25%), which was in the top
decile of all colonoscopy services in England. A total of 129
potential PCCRCs were identified in the study period. Hos-
pital records were unavailable in 9 early cases. Thirteen
cases were excluded, leaving 107 cases for final analysis
(Figure 2).
Patient Details
Fifty-five (51.4%) PCCRCs occurred in male patients. Age
range at index colonoscopy was 37 to 87 (mean 71.1, me-
dian 71). Delay between index colonoscopy and PCCRC
diagnosis ranged from 6 to 47 months (mean 24.9 months,
median 24 months). Sixty-eight PCCRCs were diagnosed
between 6 and 36 months (2.27/month) and 29 between 36
and 48 months (2.42/month).
Nine (8.4%) PCCRCs were diagnosed in patients with
IBD, and 4 (3.7%) in patients with hereditary cancer syn-
dromes (one familial adenomatous polyposis, 3 Lynch syn-
drome). Thirty patients (28%) had undergone previous
resection for CRC. Five patients (4.7%) were noted to have
multiple polyps on previous examinations. One of these
patients had 2 subsequent PCCRCs. Forty-six patients (43%)
had concurrent diverticular disease.
Twenty-six patients (24.3%) underwent more than 1
colonoscopy in the 6- to 48-month period (maximum 4).
Fifteen patients (14%) underwent 1 or more flexible sig-
moidoscopies in addition to their colonoscopy. Fifty patients
(46.7%) had radiographic imaging (computed tomography
scan/barium enema) in the 6- to 48-month period preceding
CRC diagnosis.
Cancer Details
PCCRC locations were cecum (15, 14%), ascending (15,
14%), hepatic flexure (5, 4.7%), transverse (18, 16.8%),
splenic flexure (4, 3.7%), descending (4, 3.7%), sigmoid (12,
11.2%), rectosigmoid junction (3, 2.8%), rectum (27,
25.2%), and anastomosis (1, 0.9%). In 3 cases (2.8%), the
cancer location was ambiguous. Stage at diagnosis was I (34,
31.8%), II (34, 31.8%), III (26, 24.3%), and IV (13, 12.1%)
(Figure 3). Tumor size was recorded in 95 (88.8%) of 107
PCCRCs, ranging from 1 to 200 mm in maximum diameter.
The 1-mm cancer was identified in a polyp removed endo-
scopically. There was no correlation between delay to
diagnosis and tumor size or staging (Figure 4).
Treatment for PCCRCs was surgery (67, 62.6%),
chemotherapy (4, 3.7%), radiotherapy (2, 1.9%), combina-
tion therapy (20, 18.7%), polypectomy (5, 4.7%), transanal
endoscopic microsurgery (3, 2.8%), and nil (6, 5.6%).
Treatment intent was curative in 86 (80.4%) of 107 cases
and palliative in 21 (19.6%) of 107 cases.
Immortal time bias and lead-time bias were accounted
for by ignoring deaths within 3 and 4 years of the index
colonoscopy5,19: 1-year survival at 3 and 4 years from index
colonoscopy was 76 (80%) of 95 and 59 (69.4%) of 85,
respectively.
Index Colonoscopy Details
Indication for colonoscopy included symptoms (43,
40.2%), surveillance for previous CRC (24, 22.4%), sur-
veillance of polyps/post polypectomy (16, 15%), IBD sur-
veillance (9, 8.4%), hereditary cancer surveillance (4, 3.7%),
BCSP (7, 6.5%), previous abnormal investigation (3, 2.8%),
and planned polypectomy (1, 0.9%). Anemia and rectal
bleeding were the commonest indications in symptomatic
patients.









Two reports omitted quality of preparation. Of the
remaining 105, bowel preparation was good in 73 (69.5%)
cases, satisfactory in 12 (11.4%), and poor in 20 (19.0%). In
9 (45%) of 20 cases with poor preparation no repeat/
alternative investigations were arranged and there was no
record of an explicit decision for repeat colonoscopy or
another test.
There was no electronic image capture during the study
period. Photographs were printed, attached to a paper
report, and filed in the patient record. Therefore, to assess
for photodocumentation of completion, the original endos-
copy report (with attached photographs) needed to be
reviewed. In 7 cases, the endoscopy report could only be
accessed electronically and photodocumentation of
completion could not be verified. All 7 colonoscopies were
reported as complete and PCCRC locations were transverse
(1, 14.3%), descending (1, 14.3%), and rectum (5, 71.4%).
Overall, 98 (91.6%) of 107 colonoscopies were reported
as complete. In comparison, the overall unadjusted CIR over
the period was 95.6% (rates are not adjusted for any reason
including poor preparation or stricture). Reasons for non-
completion were poor bowel preparation (2, 22.2%),
diverticulosis (2, 22.2%), stricture (2, 22.2%), looping (1,
11.1%), otherwise difficult procedure (1, 11.1%), and pa-
tient discomfort (1, 11.1%). Two (22.2%) of 9 incomplete
cases were referred for repeat colonoscopy and 4 (44.4%)
of 9 for imaging. The remaining 3 (33.3%) had no further
investigations and no documentation of decisions relating to
repeat procedures. Photodocumentation of completion was
not sought for these procedures, as the colonoscopist
recognized the noncompletion.
Of the remaining, adequate photodocumentation was
found in 33 (36.3%), inadequate (ie, not clearly showing the
ileocecal valve, terminal ileum, or appendiceal orifice) in 13
(14.3%) cases, and 45 (49.5%) had no photodocumentation
(ie, the colonoscopist had not taken a photograph).
Completion was deemed important in PCCRCs devel-
oping proximal to, and including, the hepatic flexure. Eleven
(31.4%) of 35 of the colonoscopies of patients with PCCRCs
in these locations were complete with adequate photo-
documentation (Table 1); however, 4 of these cases had
poor bowel preparation. It is appreciated that it is possible,
especially with looping in the sigmoid, the splenic flexure
may not be reached. In this circumstance, completion should
be deemed important in PCCRCs proximal to, and including,
the splenic flexure. In our service, >95% of procedures are
done with use of the Olympus (Tokyo, Japan) ScopeGuide,
making it less likely that the colonoscopist fails to appre-
ciate that the splenic flexure has not been passed. However,
we appreciate that lack of photodocumentation may have
been important in some PCCRCs proximal to the splenic
flexure or even, possibly, ones more distally.
Rectal retroflexion was documented (in the report or in
a photograph) in 16 (15%) cases. Retroflexion was deemed
important in PCCRCs developing in the rectum or rec-
tosigmoid (30 cases). The rectosigmoid was included, as
retroflexion may be a surrogate marker of careful inspection
of the distal colon. Original reports (and any associated
photographs) could not be located in 5 (16.7%) of 30 rectal
or rectosigmoid cases, so retroflexion could not be verified.
Of the remaining 25, only 6 (24%) had undergone retro-
flexion (Table 1).
Of the 100 cases with a paper colonoscopy report (and
any photographs), issues were identified in 90 (90%) cases
with 1 or more of the following: poor preparation, incom-
plete procedure, inadequately documented completion, or
lack of rectal retroflexion. Only 10 (10%) index colonos-
copies were complete, with adequate photodocumentation,
retroflexion, and good bowel preparation. This demon-
strates that even in the context of an established endoscopy
reporting system there is room for improvement in
documentation.
Findings reported at index colonoscopy were as follows:
normal (14), diverticulosis (31), polyp(s) (65), inflamma-
tion/colitis (7), strictures (3), and cancer (4). Findings in the
subsequent cancerous segment were as follows: normal (51,
52.3%), diverticulosis (11, 11.3%), polyp(s) (31, 32%),
inflammation/colitis (3, 3%), and stricture (1, 1%). The
subsequent cancerous segment was not reached in 7
(77.8%) of 9 of the incomplete colonoscopies. The
cancerous segment was ambiguous in 3 (2.8%) cases.
IBD Patients
Chromoendoscopy was used in 1 (11.1%) of 9 patients
with IBD. One patient who did not have chromoendoscopy
had segmental biopsies. Bowel preparation was poor in 4
(44.4%) of 9 and active disease was present in 6 (66.7%) of
9. All colonoscopies were reported as complete, but 4
(44.4%) of 9 had inadequate photodocumentation of
completion. Four (44.4%) of 9 cancers were located in the
rectum and none of these patients underwent retroflexion.
Figure 2. Identification of PCCRCs and *exclusions.










During the study period, 36 colonoscopists had per-
formed >200 procedures (277– 4424). A decision was
made as to whether a PCCRC developed because of technical
factors, decision-making factors, and/or administrative fac-
tors. A total of 78 (72.9%) of 107 were found to have
contributing technical factors. There was no correlation
between an individual’s technically “attributable” PCCRC
rate and the number of procedures they performed, or their
CIR or PDR. There was, however, a statistically significant
correlation (P < .05) between PCCRC rate and the PICI17
(Figure 5).
Other Influential Factors
Administrative issues affected 18 of 107 cases (in which
follow-up procedures were either delayed, or not booked by
administrative staff). In 2 of 107 cases, an active decision to
not further investigate was taken by the endoscopist or
team (in view of patient age/comorbidities). In 4 of 107
cases, the patient did not attend or declined recommended
follow-up against medical advice.
In 29 of 107 cases, the decision-making of the endo-
scopist likely influenced the development of the PCCRC,
such as an unexplained decision to not repeat the colonos-
copy after inadequate bowel preparation.
WEO Categorization
Seven PCCRCs (6.5%) could not be categorized because
the original report/photographs could not be located.
Twenty-seven (27%) PCCRCs were categorized as possible
missed lesion, prior examination adequate (A); 58 (58%)
PCCRCs were categorized as possible missed lesion, prior
examination negative but inadequate (B); 8 (8%) PCCRCs
were categorized as detected lesion, not resected (C); and 7
(7%) PCCRCs were categorized as likely incomplete resec-
tion of previously identified lesion (D) (Figure 6). If any
polyp, regardless of WEO definition, was observed in the
subsequent cancerous segment and included, the rates are
A: 23%; B: 54%; C: 12% and D 11% (Figure 6).
After detailed review by the authors, 95 of 107 PCCRCs
were deemed avoidable and 12 of 107 unavoidable. The
unavoidable cases were the 5 small PCCRCs, 1 submucosal
lesion related to anastomotic recurrence, 4 cases of patient
decision to not undergo further investigation, and 2 cases of
MDT decision to not investigate further in unwell patients
(one with widely metastatic gynecological malignancy, the
other with extreme frailty).
Discussion
This study identified all PCCRC-4y cases, over an 8-year
period, within a single endoscopy service. A total of 107
cases were subjected to a root-cause analysis to identify
contributing and avoidable factors. It is the first to report
use of WEO methodology for classifying PCCRCs. Unlike the
only other similar large study10 ours is population-based
and has not excluded important groups that are at partic-
ular risk of PCCRC. If the exclusion criteria (extremes of age,
comorbidity, and preexisting colon pathology) used in the
study of Robertson et al10 had been used in ours, 70% of our
patients would have been ineligible. A small percentage of
colonoscopy (estimated at <5%) done outside the NHS was
not captured by our study.
Despite Gloucestershire Hospitals’ status as a national
colonoscopy training center and its low unadjusted PCCRC-
3y rate of 4.7% during the study period, the analysis shows
opportunities for preventing PCCRC, suggesting PCCRC-3y
rates could, in ideal circumstances, be reduced to very low
levels, perhaps 1% to 2%. In settings with fewer high-risk
patients, PCCRC-3y target rates should be even lower.
Patient Factors Associated With PCCRC
Patient factors can be subdivided into those that put
patients at risk of PCCRC because of underlying biology and
those that adversely affect the quality of colonoscopy, such
as diverticular disease or comorbidities. This distinction is
justified because the 2 categories require different solutions,
but sometimes there is overlap. For example, in IBD there is
a biology-related increased risk and it is more difficult to
assess the colon if there is inflammation. In patients with
Figure 3. Illustration of (A)
location and (B) staging of
PCCRCs.









diverticular disease, the colonoscopy may be technically
challenging and visualization more difficult.
A high proportion of PCCRCs occurred in patients with
known colonic pathology or excess risk. Twenty-six patients
(24.3%) had more than 1 colonoscopy in the 4 years before
PCCRC diagnosis. Although multiple colonoscopies appear to
be a “redflag,” theymay reflect other risk factors.Wepropose,
based on our findings and other literature,20–23 that a sub-
group of patients is identified as having unstable or “hot”
colons. We define a “hot” colon as one with previous CRC,
multiple previous large polyps, IBD, or hereditary cancer
syndromes. Of the 107 cases reviewed, 46 (43.0%)fit into one
of these categories and have, by our definition, a “hot” or
unstable colon. These findings explain some of the database
literature but enable amore focussed approach to preventing
PCCRCs. For example, in cases with previous CRC resection,
early colonoscopy will identify a high-risk subset with mul-
tiple lesions that need early repeated colonoscopy, perhaps
even 6-monthly until it is clear the patient is in a lower-risk
category. Other studies have suggested using fecal immuno-
chemical testing after colonoscopy to identify patients at high
risk of CRC, or alternatively patients at low risk who do not
need surveillance.24 In addition, performing molecular
testing may identify patients with undiagnosed Lynch syn-
drome and increased risk of further CRC.25
More intense surveillance of high-risk groups will in-
crease demand for endoscopy, and this may lengthen waits.
However, in the context of higher-quality colonoscopy,
surveillance offers less benefit than previously thought.
Recently revised UK guidelines reflect this and will lead to a
substantial reduction in colonoscopy surveillance workload.
Ideally, surveillance of high-risk patients should be done
by the best-performing colonoscopists (possibly on dedicated
lists as occurs in the English BCSP),26 adopting longer with-
drawal times and, where appropriate, using optimal tech-
niques/technologies to identify precursor lesions. Long and
difficult procedures may lead to inattention and failure to
identify smaller precursor lesions. After lengthy polypectomy
procedures, it may be appropriate to repeat the colonoscopy
within 6 months to identify missed lesions. Patients with IBD
present a different challenge because IBD surveillance may
not be able to prevent cancer entirely. If so, then IBD-related
PCCRC within surveillance time frames is inevitable.
Our findings indicate a need for further studies to
identify the most effective way to manage these patients and
determine whether PCCRC can be prevented in these
groups.
The finding of more PCCRCs in high-risk groups is in line
with the large database and case-control literature. This
means that PCCRC-3y rates for colonoscopy services, the
potential for improvement, and target rates will differ
depending on case mix. The WEO has recommended use of
unadjusted rates for benchmarking. However, the consensus
statement fails to point out that although it is appropriate to
use unadjusted rates for comparisons between jurisdictions
where the effect of case mix is evened out, it is inappro-
priate to use unadjusted rates to make comparisons be-
tween institutions. Services that are less likely to offer
colonoscopy to high-risk groups should therefore have a
lower target PCCRC-3y rate.
Cancer Characteristics
PCCRC incidence, location, and size (varying from 1–200
mm) did not correlate with delay from index colonoscopy to
diagnosis. There was a relatively high proportion of stage I
cancers (31.8%), supporting the assumption that some
PCCRCs were precursor lesions at index colonoscopy and
thus amenable to prevention. There may be exceptions: 5
patients had very small PCCRCs and it is possible that there
Figure 4. Relationship of PCCRC size and interval between
index colonoscopy and diagnosis. NOTE. PCCRC size could
be verified in 95 cases (range 1–200 mm). The 200-mm
PCCRC was removed for scale. Broken line depicts a
growth rate of 5 mm/year. CI, confidence interval.
Table 1. (A) Illustration of the Relationship of Adequately
Documented Cecal Intubation and Importance of
Completion in Relation to Position of the PCCRC
and (B) Illustration of the Relationship of Rectal
Retroflexion and Importance of Retroflexion in
Relation to Position of the PCCRC
A
Complete with adequate photo
TotalYes No
Completion important
Yes 11 24 35
No 21 41 62





Yes 6 19 25
No 10 62 72
Total 16 81 97
NOTE. Table excludes 3 cases in which PCCRC location was
ambiguous and 7 cases in which photographs could not be
located.









was no precursor lesion visible at the time of the index co-
lonoscopy. On the other hand, these small cancers could have
been slow-growing tumors in polyps. Whether there were
precursor lesions or not, these tumors were likely asymp-
tomatic (effectively found opportunistically or with surveil-
lance) and were all stage I, carrying a good prognosis. It is
proposed that future guidance considers a tumor growth rate
(we suggest 5 mm/year) that absolves the service or indi-
vidual from responsibility for very small PCCRCs.
In contrast to other studies,7 we did not find an excess of
PCCRCs in the right colon. This may be a sample size issue
or reflect the quality of the service manifest by high rates of
completion and low rates of PCCRC.
Index Colonoscopy Factors Associated With
PCCRC
Bowel preparation was inadequate in 19.0% of index
colonoscopies compared with a rate of 5.4% in the service
overall. A potential weakness is that a recognized bowel
preparation scale was not used, and the rating of
inadequacy may have been different had one been used.
However, in cases of inadequate preparation, there was no
documented decision in 45% of cases to repeat the pro-
cedure, arrange alternative investigations, or an explicit
statement that further investigation was not appropriate.
We strongly advise colonoscopists (or the responsible
clinician) to arrange a repeat investigation if bowel prepa-
ration is considered inadequate, or to explain and document
the rationale not to investigate further in the patient record.
Poor documentation makes clinicians and services more
vulnerable to litigation.
The requirement to retroflex in the rectum is relatively
new. Of 100 cases with available photographs, rectal
retroflexion was documented in 16%. Although rectal
retroflexion will not have prevented all rectal PCCRCs, it is a
significant shortcoming. Rectal retroflexion might be a proxy
indicator for adequate visualization of the rectum (as is
withdrawal time for ADR). Rectal retroflexion (and photo-
documentation) should be, like photographic evidence of the
cecum, a key performance metric.
Figure 5. Scatterplots of “technically attributable” PCCRCs in relation to CIR, PDR, overall colonoscopy volume, and PICI.
Note. Statistically significant correlation seen for PICI (P < .05). Other plots showed no significant correlation. CI, confidence
interval.









Only 33 (36.3%) of 91 “complete” colonoscopies with
available original report and photographs had adequate
photographic evidence of completion. This reflects a lack of
appreciation of the importance of cecal photographs and
incomplete provision of the necessary equipment in the
early period. Photodocumentation of the cecum is now a key
performance metric in all guidelines. With electronic image
capture, there is no excuse for not obtaining adequate
photographs. A judgment was made as to whether lack of
adequate photographs (and therefore possible incomplete
colonoscopy) was relevant to the PCCRC. Assuming photo-
graphic evidence of completion to be relevant in PCCRCs
located at, or proximal to the hepatic flexure, only 11
(31.4%) of 35 PCCRCs had adequate photodocumentation.
Chromoendoscopy was used in 1 (11.1%) of 9 index
colonoscopies for PCCRCs developing in patients with IBD.
Chromoendoscopy may not be possible if the preparation is
poor or there is active disease (7 of 9 of our cases), and
surveillance and interpretation of biopsies may be prob-
lematic if there is active colitis. These findings emphasize
the need for adequate documentation, in this instance why
dye spray was not used, why random biopsies were not
taken, or why procedures were not repeated if they were
compromised by active inflammation. Our endoscopy ser-
vice is reorganizing IBD surveillance to overcome the
shortcomings identified in this review.
Endoscopist Factors Associated With PCCRC
A decision was made as to whether a PCCRC could be
attributed to the responsible endoscopist. Attribution was
deemed secondary to technical factors, decision-making
factors, or both. In our cohort 78 (72.9%) of 107 PCCRCs
were thought to arise, in part, because of technical factors
and 29 (27.1%) of 107 because of, with the benefit of
hindsight, unwise decisions about follow-up.
In our study, an individual’s technically “attributable”
PCCRC rate was not associated with numbers performed,
CIR, or PDR. However, there was an association with a new
measure,17 the PICI. Achieving this indicator requires cecal
intubation with minimal sedation and a comfortable patient.
High PICI may be a marker of diligence and less likelihood of
missing lesions that lead to PCCRC. However, we recognize
more studies of the relationship of PICI and PCCRC are
required.
Other Influential Factors
Patients scheduled for surveillance procedures are a
lower priority than symptomatic or screened patients
and often wait beyond their due date, but for a small
number, a delay becomes important. In this study, 18 of
107 cases were affected by administrative delays in
surveillance or planned therapeutic procedures. Sched-
uling staff cannot judge urgency and it is the re-
sponsibility of endoscopists and referring clinicians to be
clear whether a patient is in a high-risk category. In the
United Kingdom, there is a requirement for administra-
tive and clinical review of all surveillance cases before
scheduling when high-risk patients are flagged so their
procedures are not delayed.
Some PCCRCs developed after a positive decision, either
by the CRC MDT or an informed patient, not to pursue
further investigations or therapy. Although these were
theoretically avoidable, they are not attributable to a colo-
noscopist or decision-maker.
Figure 6. Categorization of PCCRCs using WEO method. NOTE. 7 cases uncategorizable as photographs were unavailable.
Figures in bold indicate percentage of cancers in each category. Percentages with (*) are those if the algorithm included all
previously visualized polyps/lesions.









Utility of the WEO Categorization
In this cohort, 85% were deemed, according to the WEO
categorization, to be possible missed lesions after a negative
colonoscopy; 15% were related to a previously seen lesion
(either resected or not resected). The low number of
incompletely resected lesions in this cohort (7%) may be
explained by the hospital being a referral center for poly-
pectomy and a low threshold locally for referring larger
and/or complex polyps to endoscopists trained to excise
them.
However, a flaw in the WEO categorization may
explain the finding. To be categorized C or D requires the
lesion in the affected segment to be an advanced ade-
noma, defined as a polyp larger than 1 cm, and/or villous
and/or containing high-grade dysplasia. In 13 cases, a
polyp had been seen at index colonoscopy, but could not
be categorized as an advanced adenoma because of the
following:
1. The polyp was <1 cm or its size was unclear on the
endoscopy report
2. The polyp was not excised/retrieved; therefore, it was
not possible to assess for villous component or high-
grade dysplasia
3. There was discrepancy between the location of the
polyp and the subsequent cancer, when it was clear
the index colonoscopist was unsure of his or her po-
sition within the colon
4. A stricture (rather than a polyp) was diagnosed at
index colonoscopy, but not biopsied and subsequently
was found to be cancerous
There were cases in which PCCRCs appeared to develop
from incompletely resected sessile serrated lesions that did
not fulfil the WEO lesion definition and were therefore
categorized as A or B PCCRCs rather than D. If all polyps in
the affected segment were included, the proportion of C or
D lesions would be higher. The new rates would be A ¼
23% (27%), B ¼ 54% (58%), C ¼ 12% (8%), D ¼ 11%
(7%).
Other flaws in the categorization relate to the omission
of information from previous colonoscopies, relevance of
completion for distal lesions, omission of rectal retroflexion
in adequacy criteria, and other factors, such as malfunc-
tioning equipment (Supplementary Material). Our data also
highlight that many PCCRCs are related to nontechnical
factors and suggest that to be clear about how to reduce
PCCRCs, these be categorized as follows:
1. Patient factors
2. Administrative process factors
3. Clinical decision-making factors
The WEO modifying statement of “deviation from the
planned management pathway” is insufficiently detailed to
enable accurate classification (examples in the
Supplementary Material).
Recommendations
Recommendation 1: Learning From Local
Experience: Identifying and Reviewing PCCRCs
This study has illustrated how a WEO-based review of
PCCRCs can lead to an in-depth understanding of PCCRCs
and avoidable factors amenable to mitigation. Although the
lessons learned are likely to be applicable to most endos-
copy services, inevitably there will be differences in other
settings. Moreover, sustained improvement is more likely if
changes are based on local learning. Thus, we strongly
support the recommendations of the WEO and the re-
quirements of the Joint Advisory Group on Gastrointestinal
Endoscopy to identify and review PCCRCs. In a moderate-
sized endoscopy service performing 6000 to 10,000 colo-
noscopies per year, this will yield 10 to 20 cases per year
(depending on rates of cancer in the service). Each endo-
scopist should receive feedback on their PCCRCs and les-
sons learned from others to identify areas for improvement.
Many services will find it difficult to identify all PCCRCs.
We recommend systems are developed to link cancer reg-
istries with registrations of colonoscopy (however they are
captured) to identify PCCRC cases and notify the service
where the index colonoscopy was performed. This will
ensure all PCCRCs are captured, and remove a significant
barrier (identifying cases) to services wanting to review
cases.
Recommendation 2: Identify and Manage High-
Risk Patients
In this study cohort, 43% of PCCRCs occurred in high-
risk patients, justifying a tailored approach to surveillance
in this group. Once identified, these patients should have
regular endoscopic surveillance (possibly supported by
periodic fecal immunohistochemistry testing), perhaps more
frequently than current guidance advises. These surveil-
lance procedures should never be delayed, extra time
should be allocated, and the procedure should probably be
done by the best-performing colonoscopists using the most
appropriate lesion recognition enhancement techniques.
Early repeat procedures should be considered after lengthy
index colonoscopies where multiple/large polyps were
resected. Patients should be warned that lesions may be
overlooked during long and difficult procedures, and an
early second look to review the resection site(s) and check
for missed lesions within 6 months is justified.
There is a need for research into the optimal protocols




Inadequate decision-making and poor documentation
played a key role in some PCCRCs. Endoscopists (and/or
responsible clinicians) are advised to consider and docu-
ment the following:









1. Whether the preparation was adequate and the
investigation complete
2. Whether a repeat colonoscopy is required:
a. If yes: when it should be scheduled
b. If no: the reason and what investigation (if any) is
recommended
3. Who is responsible for arranging and reviewing the
repeat procedure and/or investigations
4. Whether the patient was involved in decision-making
Failure to follow this guidance will leave individuals and
services vulnerable to litigation. We recommend follow-up
of inadequate/incomplete procedures is subject to audit.
Recommendation 4: Recommendations to the
WEO Categorization
On the basis of this study, we recommend some adap-
tations to the WEO categorization:
1. Rectal retroflexion and malfunctioning or inadequate
equipment should be mandatory elements of colo-
noscopy adequacy.
2. Small cancers (to be defined) should be excluded
from analysis on the basis that they are unlikely to
have been detectable at index colonoscopy and are
unlikely to have a significant impact because they are
likely to be early-stage disease.
3. There should be more flexibility regarding the defi-
nition of “advanced adenoma,” particularly if a lesion
was seen at index colonoscopy but not biopsied.
4. If a patient has undergone more than 1 colonos-
copy, the previous colonoscopies/flexible sigmoid-
oscopies should be reviewed to identify if a
precursor lesion was seen in the cancerous segment
before the index colonoscopy. If a lesion was seen
previously, this should influence the categorization
of the PCCRC.
Greater clarity is needed with respect to “deviation
from the planned management pathway.” This should be
subdivided into decision-making factors (patient choice/
clinical factors, such as comorbidity) or administrative
factors (failure to book repeat procedure at recom-
mended interval). There should be 2 further categories:
“E” (patient choice/comorbid) and “F” (administrative
issues).
Gathering and reviewing the entire WEO data set will be
too time-consuming for most endoscopy services. It is rec-
ommended the WEO create an abbreviated version for
everyday use, reserving the complete data set for academic
studies.
Finally, the WEO should reconsider use of unadjusted
PCCRC-3y rates for benchmarking purposes: there are in-
stances when there should be adjustment of PCCRC-3y
rates.
Summary and Conclusions
This is the largest, population-based study into PCCRC
causation to date and the first to use and critique the WEO
categorization. It builds on the findings of Robertson et al10
with a sample of patients that has not excluded important
high-risk groups, thereby providing a picture of why
PCCRCs occur that is more generalizable to other settings. It
provides rich learning of factors that lead to PCCRC and
indicates that much of PCCRC can be avoided.
Supplementary Material
Note: To access the supplementary material accompanying
this article, visit the online version of Gastroenterology at
www.gastrojournal.org, and at https://doi.org/10.1053/
j.gastro.2019.12.031.
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There were several cases in which the PCCRC could not
easily be categorized because of shortcomings in the WEO
categorization.
Examples, and recommendations for improvement, are
detailed as follows:
1. Definition of advanced adenoma
Patient A had an index colonoscopy 6 months before
PCCRC diagnosis. Multiple polyps were seen, including a
cancerous lesion, which was biopsied. A 9-mm polyp in the
rectum was not biopsied in view of the biopsy forceps being
used to biopsy the sigmoid cancer. After CRC resection, the
patient had a repeat colonoscopy, at which point the rectal
polyp was resected. This was a CRC (and therefore a
PCCRC). It is clear that the PCCRC developed from the rectal
lesion, which was not resected at index colonoscopy. The
PCCRC was labeled as an A (possible missed lesion, prior
examination adequate), because of its size, but if the defi-
nition of “lesion” included 9-mm polyps, this would have
been a C (detected lesion, not resected).
2. Previously observed lesions
There is some confusion when a patient has had multi-
ple colonoscopies. For example: Patient B had a colonos-
copy 43 months before PCCRC diagnosis where a proximal
transverse colon cancer was diagnosed. In addition, there
was a complex sessile polyp in the cecum and a 15-mm
sessile polyp in the proximal descending colon. Only the
transverse cancer was biopsied. The patient underwent
hemicolectomy. A CRC follow-up colonoscopy (index colo-
noscopy) commented only on diverticular disease (not the
cecal or descending polyp). Twenty-six months later the
patient presented with a 61-mm descending colon PCCRC
that most likely developed from the previously seen polyp.
This information would be missed if only the index (or most
recent) colonoscopy is reviewed. This case was categorized
as an A (possible missed lesion, prior examination
adequate), but if the previous colonoscopy had been taken
into account, it would have been categorized as a C
(detected lesion, not resected).
3. Relevance of cecal intubation
Another problem with the WEO categorization is with
the definition of “adequacy.” The method deems adequacy
as one in which the bowel preparation was adequate and
there was evidence of cecal intubation. However, evidence
of cecal intubation could be considered only relevant in
right-sided cancers. For example, in case C, a patient un-
derwent index colonoscopy for diarrhea, which found only
diverticulosis. Bowel preparation was good. Twenty-seven
months later, a PCCRC was diagnosed in the rectum. Index
colonoscopy bowel preparation was good but there was no
photographic evidence of cecal intubation, therefore the
procedure was categorized as a B. Clearly cecal intubation is
less important in this case because of the distal position of
the CRC.
4. Omission of rectal retroflexion in
categorization
There is a significant omission within the methodology
with regard to exclusion of rectal retroflexion. For example,
in case D, a patient had index colonoscopy for IBD sur-
veillance, which showed no active disease. The procedure
was complete with good bowel preparation. Twenty-seven
months later the patient presented with a 58-mm rectal
PCCRC. The index colonoscopy did not mention retroflexion
in the rectum, which would have been possible as there was
no active disease. According to the WEO categorization, this
was an A (possible missed lesion, prior examination
adequate). If retroflexion was part of the adequacy criteria
for rectal lesions this would be a B (possible missed lesion,
prior examination inadequate).
5. Other adequacy factors
There are other factors that could render the index co-
lonoscopy inadequate. For example, in case E, the index
colonoscopy was undertaken as part of the BCSP, with a 240
series Olympus colonoscope. The colonoscopist commented
that the images were flashing throughout the procedure and
that the mucosa appeared unduly red. Twenty-seven
months later, a 25-mm PCCRC was diagnosed within the
rectum. This clearly was an inadequate procedure and
should be labeled as such. According to the categorization,
however, this was an A (possible missed lesion, prior ex-
amination adequate).
6. Patient factors
Patients also influence development of PCCRC, and the
categorization does not account for this. For example, in case
F, an index colonoscopy was completed as part of the BCSP.
It was complete, with adequate photodocumentation, rectal
retroflexion, and good bowel preparation. A 4-mm tubular
adenoma polyp with low-grade dysplasia was seen in the
rectum and the patient was referred for Transanal Endo-
scopic Microsurgery. She declined this for fear of developing
fecal incontinence. Thirty-one months later she presented
with a 21-mm rectal PCCRC. In this instance, the PCCRC is an
A (possible missed lesion, prior examination adequate) (note
that it is not a C because it does not fulfil the WEO lesion
criteria). However, a precursor lesion was seen and correct
management proposed, therefore it should be labeled as
PCCRC solely because of a deviation from the planned
management pathway due to patient factors. It should not be
attributable to the index colonoscopist.
7. Administrative factors
Nonclinical administrative factors can also influence
PCCRC development. For example, in case G, an index co-
lonoscopy was completed for familial adenomatous pol-
yposis surveillance, at which time multiple polyps were
seen, as well as ascending colon and sigmoid colon CRCs.
The patient underwent subtotal colectomy but was advised
by the colonoscopist to undergo an early flexible
sigmoidoscopy of the rectal stump to further assess the
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rectal polyps. The follow-up flexible sigmoidoscopy was not
booked until 14 months afterward, and then the patient
had 3 examinations of the rectal stump within 6 months,
with rectal PCCRC being diagnosed at the last of these. This
is labeled as an A (none of the rectal lesions was biopsied
at index colonoscopy, and their size was not recorded so it
cannot be a C). However, a precursor lesion was seen and
correct management proposed. Therefore, it should be
labeled as PCCRC solely because of deviation from the
planned management pathway due to administrative fac-
tors. It should not be attributable to the index
colonoscopist.
8. Decision-making factors
Finally, the decisions made by responsible colonoscopist
can influence PCCRC development. In case H, a patient had an
index colonoscopy for IBD surveillance. It was complete with
adequate photodocumentation, but the bowel preparation
was poor. No active decision was taken to repeat the colo-
noscopy in view of the poor bowel preparation and inability
to use chromoendoscopy. A 49-mm ascending colon PCCRC
was diagnosed at repeat surveillance colonoscopy 13months
later. This case was clearly attributable to both poor prepa-
ration and a poor decision to not repeat the procedure, and
this should be reflected in the categorization.
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